Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Inducible Phase Separation of GSK3α As a Mechanism for Asparaginase Resistance in Acute Leukemias

Laura Hinze, Sabine Schreek, Andre Zeug, PhD, Evgeni Ponimaskin, PhD, Roxane Labrosse, MD FRCPC, James Degar, Gabriela Chiosis, PhD, Sung-Yun Pai, MD, Kristen E. Stevenson, MS, Donna S Neuberg, ScD, Beat Bornhauser, PhD, Jean-Pierre Bourquin, MD PhD, Martin Stanulla, MD, Alejandro Gutierrez, MD

Blood (2019) 134 (Supplement_1): 169.

https://doi.org/10.1182/blood-2019-126633

Published: 2019

Journal Articles

SWI/SNF Dysregulation through a Prion-like Domain Causes AML

Simone S Riedel, PhD, Alexandra Lenard, BS, Kevin Nestler, BS, Congcong Lu, PhD, Hongbo Xie, PhD, Benjamin A Garcia, PhD, Kathrin M. Bernt, MD

Blood (2019) 134 (Supplement_1): 2512.

https://doi.org/10.1182/blood-2019-129280

Published: 2019

Journal Articles

Thrombopoietin-Receptor Agonists the Mexican Experience: Romiplostim in 53 Non-Immune Thrombocytopenia Patients

Margarita Rodriguez-Mejorada, MD, Luis Javier Marfil-Rivera, MD, Jose Rodriguez-Carrillo, MD

Blood (2012) 120 (21): 4650.

https://doi.org/10.1182/blood.V120.21.4650.4650

Published: 2012

Journal Articles

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

Liane CJ te Boome, MD, Cristina M Mansilla, Caroline A Lindemans, MD, PhD, Lotte E Van der Wagen, MD, Marloes Cuijpers, MD, Ineke Slaper-Cortenbach, PhD, Henk Rozemuller, PhD, Eefke J Petersen, MD, PhD, Eric Spierings, PhD, Marc Bierings, Jaap J Boelens, MD, PhD, Nico Wulffraat, MD, PhD, Jurgen H Kuball, MD, PhD

Blood (2012) 120 (21): 736.

https://doi.org/10.1182/blood.V120.21.736.736

Published: 2012

Journal Articles

Multiple Dedicated Measures Result in a Plasma-Derived FVIII Concentrate with High Margin of Safety Regarding Pathogen Transmission

Albrecht Groener, Thomas Nowak, Birgit Popp, Wolfram Schäfer

Blood (2011) 118 (21): 4355.

https://doi.org/10.1182/blood.V118.21.4355.4355

Published: 2011

Journal Articles

High Margin of Pathogen Safety for a Plasma-Derived FXIII Concentrate for the Treatment of Congenital FXIII Deficiency

Albrecht Groener, Thomas Nowak, Birgit Popp, Wolfram Schäfer

Blood (2011) 118 (21): 4655.

https://doi.org/10.1182/blood.V118.21.4655.4655

Published: 2011

Journal Articles

Influence of Prion Gene Downregulation by RNAi on Erythroid Differentiation in Vitro. First Insight.

Marti N Panigaj, MS, Hana Glierova, Karel Holada

Blood (2008) 112 (11): 1338.

https://doi.org/10.1182/blood.V112.11.1338.1338

Published: 2008

Journal Articles

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

Tracy Murphy, Mary R Cahill, Jim Fagan, Croxon Harry, Mohammed Khan, Oonagh Gilligan, Stephen McGrath, William G Murphy

Blood (2008) 112 (11): 994.

https://doi.org/10.1182/blood.V112.11.994.994

Published: 2008

Journal Articles

Efficient Reduction of Prions by the Manufacturing Process of a VWF/FVIII Product

Albrecht Groener, Martin Groschup, Wolfram Schäfer

Blood (2008) 112 (11): 995.

https://doi.org/10.1182/blood.V112.11.995.995

Published: 2008

Journal Articles

A Mouse Model for Diamond-Blackfan Anemia Demonstrates a Dominant Negative Effect of a Point Mutation in the RPS19 Gene

Emily E. Devlin, BA, Lydie DaCosta, Mohandas Narla, DSc, Gene Elliott, David M. Bodine, PhD

Blood (2008) 112 (11): 38.

https://doi.org/10.1182/blood.V112.11.38.38

Published: 2008

Journal Articles

Microvesicles as immune orchestra conductors

Mariusz Z. Ratajczak

Blood (2008) 111 (10): 4832–4833.

https://doi.org/10.1182/blood-2008-02-136028

Published: 2008

Journal Articles

Normal prion protein trafficking in cultured human erythroblasts

Rebecca E. Griffiths, Kate J. Heesom, David J. Anstee

Blood (2007) 110 (13): 4518–4525.

https://doi.org/10.1182/blood-2007-04-085183

Published: 2007

Journal Articles

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

Andrea Gerhardt, MD, Kristina Stahlschmidt, MD, Ansgar Ilg, MD, Rudiger E. Scharf, MD, Rainer B. Zotz, MD

Blood (2007) 110 (11): 3947.

https://doi.org/10.1182/blood.V110.11.3947.3947

Published: 2007

Journal Articles

Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction.

Rodrigo Morales, BSc, Kimberley A. Buytaert-Hoefen, Ph.D., Eric T. Hansen, M.S., Dennis Hlavinka, M.S, Raymond Goodrich, Ph.D., Claudio Soto, Ph.D.

Blood (2007) 110 (11): 2890.

https://doi.org/10.1182/blood.V110.11.2890.2890

Published: 2007

Journal Articles

Human Mesenchymal Stem Cell Therapy: Platelet Lysate Supports Efficient Preclinical Expansion.

Katharina Schallmoser, MD, Christina Malischnik, Eva Rohde, MD, Andreas Reinisch, Christian Guelly, PhD, Gerhard Lanzer, Werner Linkesch, Dirk Strunk

Blood (2006) 108 (11): 3649.

https://doi.org/10.1182/blood.V108.11.3649.3649

Published: 2006

Journal Articles

Prion Clearance Capacity Is Improved by Modification of a Filtration Step in the Gamunex® (IGIV) Manufacturing Process.

Michael Mink, Randal Hartwell, Patricia Bauman, Michael Burdick, Michele Kislan, Mark Nelson, Renea’ Oquendo, Dominique Pifat, Kang Cai

Blood (2006) 108 (11): 3860.

https://doi.org/10.1182/blood.V108.11.3860.3860

Published: 2006

Journal Articles

Measures Taken for Effective Virus Reduction of Plasma-Derived Coagulation Factor Concentrates.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2006) 108 (11): 4009.

https://doi.org/10.1182/blood.V108.11.4009.4009

Published: 2006

Journal Articles

Human Platelet-Derived Factors Regulate Mesenchymal Stem Cell Gene Expression.

Christina Malischnik, Katharina Schallmoser, MD, Eva Rohde, MD, Andreas Reinisch, Christian Guelly, PhD, Gerhard Lanzer, Werner Linkesch, Dirk Strunk

Blood (2006) 108 (11): 4255.

https://doi.org/10.1182/blood.V108.11.4255.4255

Published: 2006

Journal Articles

The Post-Transfusion Recovery and Survival of Red Blood Cells in Mice Is Affected by the Expression of Cellular Prion Protein.

Karel Holada, PhD, Jan Simak, PhD, Jaroslav G. Vostal, MD, PhD

Blood (2006) 108 (11): 959.

https://doi.org/10.1182/blood.V108.11.959.959

Published: 2006

Journal Articles

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

Albrecht Groener, Thomas Nowak, Wolfram Schäfer

Blood (2005) 106 (11): 4170.

https://doi.org/10.1182/blood.V106.11.4170.4170

Published: 2005

NARROW

Inducible Phase Separation of GSK3α As a Mechanism for Asparaginase Resistance in Acute Leukemias

SWI/SNF Dysregulation through a Prion-like Domain Causes AML

Thrombopoietin-Receptor Agonists the Mexican Experience: Romiplostim in 53 Non-Immune Thrombocytopenia Patients

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

Multiple Dedicated Measures Result in a Plasma-Derived FVIII Concentrate with High Margin of Safety Regarding Pathogen Transmission

High Margin of Pathogen Safety for a Plasma-Derived FXIII Concentrate for the Treatment of Congenital FXIII Deficiency

Influence of Prion Gene Downregulation by RNAi on Erythroid Differentiation in Vitro. First Insight.

Phase 1 Clinical Trial of Prion-Filtered Red Cell Concentrates (pfRCC) in Patients Requiring Allogeneic Blood Transfusion.

Efficient Reduction of Prions by the Manufacturing Process of a VWF/FVIII Product

A Mouse Model for Diamond-Blackfan Anemia Demonstrates a Dominant Negative Effect of a Point Mutation in the RPS19 Gene

Microvesicles as immune orchestra conductors

Normal prion protein trafficking in cultured human erythroblasts

Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).

Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction.

Human Mesenchymal Stem Cell Therapy: Platelet Lysate Supports Efficient Preclinical Expansion.

Prion Clearance Capacity Is Improved by Modification of a Filtration Step in the Gamunex® (IGIV) Manufacturing Process.

Measures Taken for Effective Virus Reduction of Plasma-Derived Coagulation Factor Concentrates.

Human Platelet-Derived Factors Regulate Mesenchymal Stem Cell Gene Expression.

The Post-Transfusion Recovery and Survival of Red Blood Cells in Mice Is Affected by the Expression of Cellular Prion Protein.

Two Virus Reduction Steps Are Inherent in the Manufacturing Process of Berinert P, a C1-Esterase-Inhibitor Concentrate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only